Bioventus Inc (BVS)
8.38
-5.33
(-38.88%)
USD |
NASDAQ |
Nov 05, 09:53
Bioventus Cash from Investing (Quarterly): -0.077M for June 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -0.077M |
| March 31, 2024 | -1.00M |
| December 31, 2023 | -0.591M |
| September 30, 2023 | -2.036M |
| June 30, 2023 | 33.50M |
| March 31, 2023 | -15.07M |
| December 31, 2022 | -3.403M |
| September 30, 2022 | -56.33M |
| June 30, 2022 | -52.02M |
| March 31, 2022 | -4.674M |
| Date | Value |
|---|---|
| December 31, 2021 | -221.28M |
| September 30, 2021 | -13.19M |
| June 30, 2021 | -2.648M |
| March 31, 2021 | -46.65M |
| December 31, 2020 | -1.711M |
| September 30, 2020 | -17.76M |
| June 30, 2020 | -0.579M |
| March 31, 2020 | -0.451M |
| March 31, 2016 | -6.638M |
| March 31, 2015 | -0.306M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-221.28M
Minimum
Dec 2021
33.50M
Maximum
Jun 2023
-22.55M
Average
-3.026M
Median
Cash from Investing (Quarterly) Benchmarks
| Boston Scientific Corp | -1.427B |
| Insulet Corp | -24.90M |
| Perspective Therapeutics Inc | -3.295M |
| Xtant Medical Holdings Inc | -0.48M |
| Catheter Precision Inc | -0.045M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 15.16M |
| Cash from Financing (Quarterly) | -7.845M |
| Free Cash Flow | 8.443M |
| Free Cash Flow Per Share (Quarterly) | 0.2355 |
| Free Cash Flow to Equity (Quarterly) | 23.04M |
| Free Cash Flow to Firm (Quarterly) | 23.16M |
| Free Cash Flow Yield | 1.59% |